Coronavirus | There is no vaccine shortage, says Health Ministry

No word yet on when Moderna and the Johnson & Johnson vaccines will be available in India

August 26, 2021 08:52 pm | Updated 08:52 pm IST - NEW DELHI

Coronavirus vaccination in progress at a centre in New Delhi on August 26, 2021.

Coronavirus vaccination in progress at a centre in New Delhi on August 26, 2021.

India isn’t facing any shortage of COVID vaccine right now, Health Secretary Rajesh Bhushan said on Thursday. He was responding to a question about some COVID vaccines that have got their Emergency Use Authorisation (EUA) but are still not available for the Indian population.

At a Health Ministry media conference on Thursday, Mr. Bhushan said that India currently has surplus stock. The Central government has asked States to improve the rate at which vaccination is being done.

India has currently granted EUA to Bharat Biotech’s Covaxin, Serum Institute’s Covishield and Russian vaccine Sputnik V, all of which are available to the Indian population. EUA has also been granted to Moderna’s vaccine (to be imported by Cipla), the Johnson & Johnson single dose vaccine and Zydus Cadila’s ZyCoV-D.

ZyCoV-D may be available by October. The Central Government has noted that they are in talks to bring in the other vaccines into Indian markets soon.

Mr. Bhushan said that India is currently in a comfortable place in terms of availability of vaccines and noted that states have surplus vaccine stock at present. He however cautioned that the second wave isn’t over in India and said that people need to continue adherence to safety norms. He said that 58.4% of the total COVID cases last week was reported from Kerala.

“Overall, a declining trend has been observed across India in weekly positivity since the week ending May 10 and the weekly positivity less than 3% for the eighth consecutive week. 41 districts in India are reporting more than 10% weekly positivity,” he said.

N.K. Arora, chairman of the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI), said that vaccine effectiveness data is being reviewed on a regular basis. He noted that currently there is no proposal for change in the dosage interval for Covishield, Covaxin and Sputnik V.

Meanwhile, the Health Ministry, in a release, stated that Health Minister Mansukh Mandaviya on Thursday took over charge as chairperson of the Stop TB Partnership Board.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.